Archive for David Altman
Microbiome therapeutics: 6 takeaways from a MassBio panel
Seeing the surprising success of “poop pills” in gastrointestinal C. difficile infection, pharma companies and startups are embracing the microbiome as a new therapeutic target for an astonishing range of maladies. To learn what pioneering companies in the space are thinking about the hope and the hype, Vector recently attended a panel on microbiome therapeutics ... Read More
Cloud-based complex care platform empowers clinicians and families alike
For children with complex medical needs, care coordination across medical specialties is a major pain point, as is communication across multiple provider systems. And patients aren’t the only ones feeling the burden. Consider these startling statistics: $25-$45 billion is wasted annually in the U.S. due to poor communication in health care.$45 billion has been invested in ... Read More